{"transactions":[{"id":1066046,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":76497,"kind":"person","name":"Landon Kristen","position":1,"cik":"0002053910","reported_name":"Landon Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-08-15T01:24:37.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The options shall vest and become exercisable in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024. The options have a maximum term of 10 years from the date of grant."},{"field":"security","element":"securityTitle","label":"F2","text":"This Form 4 is being filed late due to an inadvertent administrative error."},{"field":"security","element":"securityTitle","label":"F3","text":"All information has been retroactively adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted pursuant to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The options shall vest and become exercisable in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024. The options have a maximum term of 10 years from the date of grant."}],"balance_after":4167,"derivative":{"exercise_price":6.85,"expiration_date":"2034-09-26","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001213900-25-076984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025076984/ownership.xml","form_type":"4"}},{"id":1066045,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":76497,"kind":"person","name":"Landon Kristen","position":1,"cik":"0002053910","reported_name":"Landon Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-08-15T01:23:53.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed late due to an inadvertent administrative error."},{"field":"security","element":"securityTitle","label":"F2","text":"The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025."}],"balance_after":4540,"source":{"system":"sec-edgar","filing":"0001213900-25-076983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025076983/ownership.xml","form_type":"4"}}]}